Reaction of chromium(VI) with one equivalent of ascorbate was studied by electron paramagnetic resonance spectroscopy in the presence of 0.10 M 5,5-dimethyl-1-pyrroline-1-oxide (DMPO) at room temperature in 0.10 M (N-12-hydroxyethyl]piperazine-N'-[2-ethanesulfonic acid]) (HEPES) and 0.05 M tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCI) buffers (pH 7.0, room temperature). Chromium(V), ascorbyl radical, and carbonbased DMPO-radical adducts were observed. A higher level of Cr(V) was observed in HEPES buffer and a higher level of the DMPO-radical adducts was observed in Tris-HCI buffer. Chromium-DNA binding studies were carried out in vitro for calf thymus DNA incubated with Cr(VI) and ascorbate in both buffers at 37°C. Higher Cr-DNA binding was observed in HEPES buffer. DNA strand-break studies were carried out in vitro on pBR322 DNA incubated with Cr(VI) and ascorbate in both buffers at 37°C. Higher percent nicking was observed in Tris-HCI buffer. Addition of DMPO decreased nicking levels in Tris-HCI buffer. These results suggest that free radicals are more reactive than Cr(V) in producing DNA strand breaks and that Cr(V) will react with DNA to produce Cr-DNA adducts. The fact that buffer affects the nature of the reactive intermediates produced upon reduction of Cr(VI) may be related to differences in intracellular metabolism of Cr(VI) and resulting DNA damage observed in various cell culture systems and animal tissues in vivo. -Environ Health Perspect 102(Suppl 3): 21-25 (1994).
Introduction
Chromium(VI) (Cr(VI) is a known carcinogen (1) . It causes respiratory cancers in humans and animals, and it is mutagenic and genotoxic (2) . The mechanism of Cr(VI)-induced carcinogenesis is unclear. The intracellular reduction of Cr(VI) (3) can produce many reactive intermediates, including Cr(V), Cr(IV), free radicals, and the final stable product Cr(III). Any of these species could potentially target DNA. Many types of DNA damage have been observed with Cr(VI) in vivo and in vitro, including interstrand cross-links, DNAprotein cross-links, strand breaks, Cr-DNA adducts, and radical DNA adducts, most notably 8-oxo-deoxyguanosine (4) . Recent work has shown that ascorbate (vitamin C) is the principal reductant of Cr(VI) in rat kidney, liver, and lung ultrafiltrates (5, 6) . It is not yet fully understood whether the intracellular reduction of Cr(VI) by ascorbate is a toxification or detoxification process, i.e., does ascorbate protect tissues against Cr(VI)-induced DNA damage by reducing it to a substitutionally inert form, Cr(III): 2Cr(VI) + 3ascorbate -e 2Cr(III) + 3dehydroascorbate or does this process produce reactive intermediates that are the actual genotoxic species?
The purpose of the current study was to determine the reactive intermediates that are produced upon reduction of Cr(VI) by ascorbate and the extent to which these intermediates, e.g., Cr(V) and free radicals, would react with DNA in vitro. Chromium(VI) was reacted with one equivalent of ascorbate in (N- [2-hydroxyethyl] buffer. It would be expected that ascorbate radical would be less reactive with DNA than the carbon-based radicals since ascorbate radical is too stable to react with DMPO. The Cr-DNA binding results presented here are consistent with previous work that showed a correlation between Cr-DNA adducts and Cr(V) produced from the reaction of Cr(VI) with dithiothreitol, ,Bmercaptoethanol, cysteine, and glutathione (13) . While the role of free radicals in DNA cleavage has been established above and elsewhere (14) , the reactivity of Cr(V) with DNA in terms of producing single strand breaks is less clear. Farrell et al. (15) have reported that the Cr(V) complex of 2-ethyl-2-hydroxybutanoate caused strand breaks in pUC9 DNA at pH<5; however, instability of the Cr(V) complex at higher pH prevented the same study at physiologic pH. Kortenkamp et al. (16) observed strand breaks in bacteriophage PM2 DNA after incubation with a Cr(V) species prepared from the reduction of Cr(VI) by glutathione; however, this nicking was shown later to be dependent on contaminating iron (17) . A different reactivity toward DNA for Cr(V) vs free radicals was observed for the reduction of Cr(VI) by gluthathione in the presence or absence of H202 (18) where single-strand breaks were only observed in the presence of H202 under conditions which were shown to generate hydroxyl radical, -OH. In the absence of H202, the Cr(V) that was generated upon reaction of Cr(VI) with glutathione produced Cr-DNA adducts only. Under our experimental conditions the free radicals were more reactive than Cr(V) in the production of single-strand breaks, since the level of strand breakage correlated with level of free radicals but not with Cr(V), and since DMPO, a radical trap that did not affect Cr(V), decreased the level of strand breakage. However, the lack of Cr(V)'s reactivity was not determined.
There is evidence to suggest that Cr(V) and radical intermediates will produce similar types of DNA damage in in vivo systems. Chromium(V) has been shown to have a significant lifetime in vivo (19, 20) . Chromium(V) has been detected by EPR in chick embryo red blood cells (19) and liver (20) (19) (20) (21) , in which the DNA damage in different tissues was observed to be consistent with the presence or absence of Cr(V) and radicals. A broader picture is emerging that suggests a role for Cr(V) as the ultimate genotoxic form of chromium, but also suggests that different reducing environments will affect the formation and stability of reactive intermediates, thus producing varying types of DNA damage in different tissues or assay systems.
